• About Us
  • Privacy Policy
  • Cookie Policy
  • Disclaimer
  • Copyrights
  • Contact Us

Total Reporter

Get Latest News Updates

  • Home
  • Entertainment
  • Technology
  • Sports
  • News
  • Business
  • Jobs
  • Education
  • Gaming

First Vaccine for chikungunya developed by Scientists

October 11, 2024 by Wilson Leave a Comment

Chikungunya was a disease which had no medicinal or vaccine cure. The only way to be protected from it was by preventing mosquito bites. Now the news we waited to hear about Chikungunya has finally come. A vaccine has been developed by researchers to cure the Chikungunya disease.

It is the researchers from the University of Texas Medical Branch who developed the world’s first Chikungunya vaccine. The vaccine also does not affect the human body in any way. This is because the vaccine is made from a purely inspect-specific virus. “Since it does not in any way affect the human body, it’s safe too”, says the research team.

The test results indicate that the vaccine is also a quick acting one.  “The vaccine could provide affordable protection against Chikungunya, and this could also lead to

Newer thinking of developing new vaccines from insect-specific viruses”, says the UTMB professor Scott Weaver, who is the senior author of this paper.

Chikungunya is a virus that caused disease characterised by fever and severe joint pain. The disease is caused by infected mosquito bites. The joint pain can last for a few weeks or years, in some people. Death is infrequent, but chances cannot be excluded.

Virus Used for Vaccine developing

The virus used as a vaccine platform is the Eilat virus, which infects only insects and cannot infect humans. The vaccine is a custom-made/hybrid virus made by introducing Chikungunya structural proteins into the existing insect-specific Eilat virus. This vaccine or hybrid virus is structurally identical to the natural Chikungunya virus.

Working of the vaccine

The vaccine, when injected to a diseased body, induces neutralising antibodies in the infected organism.  The speciality of the virus is its rapid action in antibody production and thereby providing a quicker immune defence. When tested in two different kinds of mouse, the antibodies showed giving complete protection from the disease. When tested in non-human primates, the vaccinated animals showed neither signs of Chikungunya virus in their blood nor the sign of illness in their body.

Filed Under: News

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

Bigg Boss Kannada Season 12 Finalists, Grand Finale Date, Time and More Details

Lunar New Year 2026 Date, When is Lunar New Year Celebrated in 2026?

Highest Grossing Indian Films Released in 2025

Sarvam Maya Malayalam Movie OTT Release Date and Platform

Lohri 2026 Date, When is Lohri Celebrated in 2026?

Avatar Fire And Ash OTT Release Date and Platform

India Squad for the T20 World Cup 2026

Winner of Single Pasanga Grand Finale 2025

POPULAR CATEGORY

  • Business
  • Education
  • Entertainment
  • Gaming
  • Jobs
  • News
  • Sports
  • Technology

TRENDING POSTS

  • Bigg Boss Kannada Season 12 Finalists, Grand Finale Date, Time and More Details
  • Lunar New Year 2026 Date, When is Lunar New Year Celebrated in 2026?
  • Highest Grossing Indian Films Released in 2025
  • Sarvam Maya Malayalam Movie OTT Release Date and Platform
  • Lohri 2026 Date, When is Lohri Celebrated in 2026?

DMCA.com Protection Status

Copyright © 2025 Total Reporter. All rights reserved.